| 07/23 | JOHNSON & JOHNSON : UBS Adjusts Johnson & Johnson's Price Target to $183 From $1.. | MT |
| 06/01 | JOHNSON & JOHNSON : Credit Suisse reiterates its Buy rating | MD |
| 05/31 | TODAY'S ANALYST RECOMMENDATIONS : Advanced Micro Devices, AstraZeneca, Bodycote,.. | |
| 05/28 | JOHNSON & JOHNSON : Morgan Stanley Assumes Johnson & Johnson at Overweight with .. | MT |
| 01/28 | JOHNSON & JOHNSON : DA Davidson Adjusts Price Target on Johnson & Johnson to $18.. | MT |
| 01/27 | JOHNSON & JOHNSON : UBS Adjusts Johnson & Johnson's Price Target to $180 From $1.. | MT |
| 01/27 | JOHNSON & JOHNSON : SVB Leerink Adjusts Johnson & Johnson's Price Target to $200.. | MT |
| 01/27 | JOHNSON & JOHNSON : Morgan Stanley Adjusts Johnson & Johnson's Price Target to $.. | MT |
| 01/27 | JOHNSON & JOHNSON : Cowen Adjusts Johnson & Johnson's Price Target to $195 From .. | MT |
| 01/27 | JOHNSON & JOHNSON : Raymond James Adjusts Johnson & Johnson's Price Target to $1.. | MT |
| 01/27 | JOHNSON & JOHNSON : Cantor Fitzgerald Adjusts Johnson & Johnson's Price Target t.. | MT |
| 01/27 | JOHNSON & JOHNSON : Credit Suisse Adjusts Johnson & Johnson's Price Target to $1.. | MT |
| 01/27 | JOHNSON & JOHNSON : Stifel Nicolaus Adjusts Price Target for Johnson & Johnson t.. | MT |
| 01/27 | JOHNSON & JOHNSON : Goldman Sachs Adjusts Price Target for Johnson & Johnson to .. | MT |
| 01/27 | JOHNSON & JOHNSON : JP Morgan Adjusts Price Target for Johnson & Johnson to $175.. | MT |
| 01/27 | JOHNSON & JOHNSON : Wells Fargo Adjusts Johnson & Johnson's Price Target to $190.. | MT |
| 01/20 | JOHNSON & JOHNSON : UBS Adjusts Price Target on Johnson & Johnson to $170 From $.. | MT |
| 2020 | JOHNSON & JOHNSON : Zacks Adjusts Johnson & Johnson's Price Target to $161 from .. | MT |
| 2020 | JOHNSON & JOHNSON : Morgan Stanley Adjusts Price Target for Johnson & Johnson to.. | MT |
| 2020 | JOHNSON & JOHNSON : Credit Suisse gives a Buy rating | MD |
| 2020 | J&J, Biotech Firm In $6.5 Billion Deal J&J Agrees to Buy Biotech Company -- W.. | DJ |
| 2020 | Pharma Companies Split on Coronavirus Vaccine Pricing Plans | DJ |
| 2020 | JOHNSON & JOHNSON : Beats Analysts' Profit Expectations for 2Q | DJ |
| 2020 | GENMAB : Darzalex Meets Main Endpoint in Light-Chain Amyloidosis Study | DJ |
| 2020 | Drugmakers see long road ahead in coronavirus vaccine race | RE |
| 2019 | J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample | RE |
| 2019 | JOHNSON & JOHNSON : Goldman Sachs maintains a Buy rating | MD |
| 2019 | JOHNSON & JOHNSON : Credit Suisse reiterates its Buy rating | MD |
| 2019 | JOHNSON & JOHNSON : J&J warns of hit from generic drugs in third quarter, shares.. | RE |
| 2019 | JOHNSON & JOHNSON : J&J warns of hit from generic drugs in third quarter, shares.. | RE |
| 2019 | JOHNSON & JOHNSON : Credit Suisse keeps its Buy rating | MD |
| 2019 | JOHNSON & JOHNSON : RBC reaffirms its Buy rating | MD |
| 2019 | GLOBAL MARKETS LIVE : LVMH, Burberry, Facebook, Tesla… | |
| 2019 | Bristol-Myers plans to divest Celgene's psoriasis drug, shares slide | RE |
| 2019 | Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value | RE |
| 2019 | Emerging markets to fuel Smith & Nephew revenue growth in 2019 | RE |
| 2018 | Biotech incubator taps investors through in-house brokerage | RE |
| 2018 | U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict | RE |
| 2018 | J&J nears diabetes device exit with $2.1 bln LifeScan sale | RE |
| 2018 | Johnson & Johnson nears diabetes device exit with $2.1 billion LifeScan sale | RE |
| 2018 | Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom | RE |
| 2018 | Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion | RE |
| 2018 | Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion | RE |
| 2018 | Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion | RE |
| 2017 | European shares reverse early losses, DAX immune to political worries | RE |
| 2017 | FTSE weighed down by housebuilders and strong pound | RE |
| 2017 | U.S. dollar up, yield curve flat, on inflation; stocks rise | RE |
| 2017 | U.S. dollar up, yield curve flat, on inflation; stocks rise | RE |
| 2017 | Germany's Merck hires JP Morgan to sell consumer health | RE |
| 2017 | Nestle plan hailed as only the start of Schneider's shake-up | RE |
| 2017 | Nestle plan hailed as only the start of Schneider's shake-up | RE |
| 2017 | Stroke drug Xarelto, plastics lift Bayer earnings | RE |
| 2017 | Morgan Stanley bags big spots on Unilever, Reckitt deals - sources | RE |
| 2017 | Johnson & Johnson refills drug cabinet with $30 billion Actelion deal | RE |
| 2017 | Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
| 2016 | Pfizer to start shipping biosimilar version of J&J's Remicade in November | RE |
| 2016 | Moody's reviews Microsoft credit rating for cut after LinkedIn deal | RE |
| 2016 | Cheap oil smudges Exxon's long-held sterling credit rating | RE |
| 2016 | No quick fix seen for Novartis's troubled Alcon unit | RE |
| 2015 | Big business on winning side in U.S. top court's major rulings | RE |
| 2015 | CELLTRION : J&J cuts full-year forecast due to strong dollar | RE |
| 2015 | AbbVie CEO defends Pharmacyclics deal to sceptical investors | RE |
| 2015 | Cardinal to buy J&J vascular technology unit Cordis for $1.9 billion | RE |
| 2014 | Johnson Matthey optimistic for full-year | RE |
| 2014 | Sodexo cuts sales growth forecast due to contract delays | RE |
| 2014 | Bayer wins Merck & Co's $14 billion consumer unit auction | RE |
| 2014 | Bayer wins Merck & Co's $14 billion consumer unit auction | RE |
| 2014 | Johnson Matthey says outlook brighter, names new CEO | RE |
| 2013 | Factbox - U.S. biotech shares outpace broader stock market | RE |
| 2013 | Elan rejects Royalty bid as grossly undervaluing its prospects | RE |
| 2013 | Elan rejects Royalty bid as grossly undervaluing its prospects | RE |
| 2013 | Ahead of reform, medical care slowdown hits companies | RE |
| 2013 | Analysis - Ahead of reform, medical care slowdown hits U.S. companies | RE |
| 2013 | J&J stake sale clouds Royalty bid for Elan | RE |
| 2013 | Elan bid to fend off Royalty handed boost in buyback | RE |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
